{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:30Z","timestamp":1787009970645,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/ftd.0b013e31828abb1d","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T08:25:47Z","timestamp":1371630347000},"page":"450-458","source":"Crossref","is-referenced-by-count":18,"title":["Analysis of Cyclosporin A in Hair Samples From Liver Transplanted Patients"],"prefix":"10.1097","volume":"35","author":[{"given":"Alexander","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilke","family":"Jungen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Iwersen-Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sterneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilke","family":"Andresen-Streichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","first-page":"299","article-title":"The controversial early history of cyclosporin.","volume":"131","author":"Heusler","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01986686","article-title":". Biological effects of cyclosporin A: a new antilymphocytic agent.","volume":"43","author":"Borel","year":"1994","journal-title":"Agents Actions"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1056\/NEJM200006153422414","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Sam","year":"2000","journal-title":"N Engl J Med"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/bmj.293.6554.1057","article-title":". Blood cyclosporin concentrations and renal allograft dysfunction.","volume":"293","author":"Holt","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R5-4-20210129","first-page":"33","article-title":"Cyclosporin therapeutic drug monitoringan established service revisited.","volume":"24","author":"Morris","year":"2003","journal-title":"Clin Biochem Rev"},{"key":"R6-4-20210129","first-page":"748","article-title":". Radioimmunoassay of hair for determining opiate-abuse histories.","volume":"20","author":"Baumgartner","year":"1979","journal-title":"J Nucl Med"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-4347(99)00059-6","article-title":"Hair analysis for abused and therapeutic drugs.","volume":"733","author":"Nakahara","year":"1999","journal-title":"J Chromatogr B"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/clinchem\/44.10.2158","article-title":". Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.","volume":"44","author":"Schutz","year":"1998","journal-title":"Clin Chem"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00007691-199302000-00012","article-title":". A reliable high-performance liquid chromatography assay for high-throughput routine cyclosporin A monitoring in whole blood.","volume":"15","author":"Salm","year":"1993","journal-title":"Ther Drug Monit"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.transproceed.2005.03.149","article-title":". Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters.","volume":"37","author":"Vollenbroeker","year":"2005","journal-title":"Transplant Proc"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jchromb.2010.03.032","article-title":". Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry.","volume":"878","author":"Fang","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/clinchem\/34.1.34","article-title":". Liquid-chromatographic measurement of cyclosporin A and its metabolites in blood, bile, and urine.","volume":"34","author":"Christians","year":"1988","journal-title":"Clin Chem"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/FTD.0b013e318236315d","article-title":". Measurement of cyclosporine A in rat tissues and human kidney transplant biopsiesa method suitable for small.","volume":"33","author":"Noll","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/rcm.323","article-title":". High-throughput semi-automated 96-well liquidliquid extraction and liquid chromatographymass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood.","volume":"15","author":"Brignol","year":"2001","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/clinchem\/48.1.69","article-title":". Rapid liquid chromatography-tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range.","volume":"48","author":"Keevil","year":"2002","journal-title":"Clin Chem"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF02432123","article-title":"Concentrations of 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.","volume":"108","author":"Kauert","year":"1996","journal-title":"Int J Legal Med"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.jchromb.2011.05.034","article-title":"Screening and quantitation of multiclass drugs of abuse and pharmaceuticals in hair by fast liquid chromatography electrospray time-of-flight mass spectrometry.","volume":"879","author":"Dominguez-Romero","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0379-0738(94)01624-E","article-title":". Simultaneous quantification of opiates, cocaine and cannabinoids in hair.","volume":"70","author":"Jurado","year":"1995","journal-title":"Forensic Sci Int"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/FTD.0b013e3181897cfa","article-title":". Screening for basic drugs in hair of drug addicts by liquid chromatographytime-of-flight mass spectrometry.","volume":"30","author":"Pelander","year":"2008","journal-title":"Ther Drug Monit"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.forsciint.2011.10.018","article-title":"Value of the concept of minimal detectable dosage in human hair.","volume":"218","author":"Kintz","year":"2012","journal-title":"Forensic Sci Int"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-199325020-00001","article-title":"Therapeutic drug monitoring in hair samples. Principles and practice.","volume":"25","author":"Uematsu","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0379-0738(94)01626-G","article-title":"Hair analysis: a worthless tool for therapeutic compliance monitoring.","volume":"70","author":"Tracqui","year":"1995","journal-title":"Forensic Sci Int"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00679777","article-title":". Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study.","volume":"37","author":"Uematsu","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0379-0738(93)90273-D","article-title":"Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GCMS and its application to a methadone treatment program.","volume":"63","author":"Moeller","year":"1993","journal-title":"Forensic Sci Int"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/096032719201100511","article-title":". Determination of amitriptyline in the hair of psychiatric patients.","volume":"11","author":"Tracqui","year":"1992","journal-title":"Hum Exp Toxicol"},{"key":"R28-4-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jat\/22.3.231","article-title":". Dose-concentration relationships in hair from subjects in a controlled heroin-maintenance program.","volume":"22","author":"Kintz","year":"1998","journal-title":"J Anal Toxicol"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0379-0738(93)90250-E","article-title":"Immunoassay evidence for fentanyl in hair of surgery patients.","volume":"61","author":"Wang","year":"1993","journal-title":"Forensic Sci Int"},{"key":"R30-4-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0379-0738(83)90108-1","article-title":"Opiate levels in hair.","volume":"21","author":"Puschel","year":"1983","journal-title":"Forensic Sci Int"},{"key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02432122","article-title":"A discourse on human hair fibers and reflections on the conservation of drug molecules.","volume":"108","author":"Potsch","year":"1996","journal-title":"Int J Legal Med"},{"key":"R32-4-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2133.2001.04350.x","article-title":"African hair growth parameters.","volume":"145","author":"Loussouarn","year":"2001","journal-title":"Br J Dermatol"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1523-1747.ep12551679","article-title":"Human hair cycle.","volume":"54","author":"Saitoh","year":"1970","journal-title":"J Invest Dermatol"},{"key":"R34-4-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.1991.tb06058.x","article-title":"Measurement of human hair growth by optical microscopy and image analysis.","volume":"125","author":"Hayashi","year":"1991","journal-title":"Br J Dermatol"},{"key":"R35-4-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2230.1987.tb01893.x","article-title":"Hypertrichosis in patients receiving cyclosporine therapy.","volume":"12","author":"Wysocki","year":"1987","journal-title":"Clin Exp Dermatol"},{"key":"R36-4-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1523-1747.ep12468979","article-title":"Cyclosporin A prolongs human hair growth in vitro.","volume":"100","author":"Taylor","year":"1993","journal-title":"J Invest Dermatol"},{"key":"R37-4-20210129","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0041-1345(98)00229-2","article-title":". Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.","volume":"30","author":"Busque","year":"1998","journal-title":"Transplant Proc"},{"key":"R38-4-20210129","first-page":"812","article-title":"Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring Hum Exp Toxicol.","volume":"14","author":"Kintz","year":"1995","journal-title":""},{"key":"R39-4-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/clpt.1988.42","article-title":". Therapeutic drug monitoring.","volume":"43","author":"Spector","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"R40-4-20210129","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(05)79831-7","article-title":". Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy.","volume":"352","author":"Bernard","year":"1998","journal-title":"Lancet"},{"key":"R41-4-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/clpt.1993.132","article-title":"Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.","volume":"54","author":"Lindholm","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R42-4-20210129","first-page":"2787","article-title":"Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients.","volume":"26","author":"Schroeder","year":"1994","journal-title":"Transplant Proc"},{"key":"R43-4-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00007691-198905000-00005","article-title":"Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.","volume":"11","author":"Grevel","year":"1989","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31828abb1d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:40:47Z","timestamp":1620938447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201308000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31828abb1d","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}